At the ASCO® Annual Meeting, Dr. Hamilton, Director of the Breast Cancer and Gynecologic Cancer Research Program at Sarah Cannon Research Institute, explains the opportunities of molecular profiling in selecting patient’s therapy and predicting response to treatment as well as common challenges and questions patients may have.
